SCHEMBL25299576

SCHEMBL25299576

Cc1ccnc(CNC=O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.44
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
UHRF1 Q96T88 1/20 0.41
CCR1 P32246 1/20 0.41
CCR5 P51681 1/20 0.41
CCR8 P51685 1/20 0.41
NOS2 P35228 2/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
KDM4E B2RXH2 2/20 0.38
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
POLB P06746 1/20 0.37
ADH1B P00325 1/20 0.37
ADH1C P00326 1/20 0.37
ADH1A P07327 1/20 0.37
ADH7 P40394 1/20 0.37
ALDH1A1 P00352 2/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21377000 0.82 FDPS (0.42) ALDH1A1FDPS
SCHEMBL21355793 0.79 ADH1B (0.37) CCR1KMT2AKDM4EPOLBADH1B
SCHEMBL29705247 0.79 KDM4E (0.38) CCR5MEN1KMT2AKDM4EADH1B
SCHEMBL1050596 0.79 KDM4E (0.38) CCR5MEN1KMT2AKDM4EADH1B
SCHEMBL21355854 0.78 NOS2 (0.53) CCR1CCR5CCR8NOS2NOS3
SCHEMBL2259096 0.78 KDM1A (0.47) KDM1AMAOAMAOBUHRF1CCR1
SCHEMBL10061638 0.77 KDM1A (0.49) KDM1AMAOAMAOBUHRF1CCR1
SCHEMBL27974103 0.76 UHRF1 (0.42) KDM1AMAOAMAOBUHRF1CCR1
SCHEMBL4030600 0.76 UHRF1 (0.45) KDM1AMAOAMAOBUHRF1CCR1
SCHEMBL22581521 0.75 KMT2A (0.49) KDM1AMAOAMAOBNOS2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230286973-A1 PROTEIN SECRETION INHIBITORS ENODIA THERAPEUTICS SAS (FR) 2023-09-14 US disclosed
US-20230286973-A1 PROTEIN SECRETION INHIBITORS ENODIA THERAPEUTICS SAS (FR) 2023-09-14 US disclosed
US-20230286973-A1 PROTEIN SECRETION INHIBITORS ENODIA THERAPEUTICS SAS (FR) 2023-09-14 US disclosed
EP-4204417-A1 PROTEIN SECRETION INHIBITORS Kezar Life Sciences (US) 2023-07-05 EP disclosed
WO-2022047347-A1 PROTEIN SECRETION INHIBITORS KEZAR LIFE SCIENCES (US) 2022-03-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230286973-A1 PROTEIN SECRETION INHIBITORS SEC61B, SEC61A1, SEC61G KDM1A 4300/4885MAOA 3697/4885MAOB 3231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.